ScitoVation logo
  • Services
    • Common Problems We Solve
      • Predicting Equivalent Dose in Humans
      • Understanding the Mode of Action of a Compound
      • Screening and Assessing Lead Compounds
    • Technologies
      • In vitro to in vivo extrapolation (IVIVE)
      • PBPK Modeling
      • Toxicogenomic or Pharmacogenomic Studies
    • Organ Specific
      • Liver toxicity
      • Respiratory Toxicity
      • Thyroid toxicity
    • Industries
      • Chemical Manufacturers and Consumer Products
      • Industry Associations
      • Pharma
  • Publications
  • Tools
    • MoAVIZ
    • PLETHEM
    • TTC Data Mart
  • Resources
    • Blog
    • Webinar
    • Case Studies
  • About us
    • Our Story
    • Team
    • Mission, Vision, Values
    • Careers
    • Scitovation, LLC. PHS-Financial Conflict Of Interest (FCOI) Policy
    • News
  • Request For Quote

Latest News

Featured image for “ScitoVation and BioPredic International Announce Partnership for HepaRG® Contract Service & Research in the Americas”
March 26, 2020

ScitoVation and BioPredic International Announce Partnership for HepaRG® Contract Service & Research in the Americas

Read More
Featured image for “Developing Toxicity and Pharmacokinetic Models for an in vitro  Integrated Organ Platform (HuDMOP™)”
March 24, 2020

Developing Toxicity and Pharmacokinetic Models for an in vitro Integrated Organ Platform (HuDMOP™)

Read More
Featured image for “An Open Source in silico Prediction Model of Hepatic Intrinsic Clearance for in vitro to in vivo Extrapolation”
March 20, 2020

An Open Source in silico Prediction Model of Hepatic Intrinsic Clearance for in vitro to in vivo Extrapolation

Read More
Featured image for “Development of additional workflows for risk assessment and prioritization for the PLETHEM R Package”
March 19, 2020

Development of additional workflows for risk assessment and prioritization for the PLETHEM R Package

Read More
Featured image for “Hepatotoxic Response in 2D and 3D Co-culture Models Differs From Hepatocyte-alone Models”
March 19, 2020

Hepatotoxic Response in 2D and 3D Co-culture Models Differs From Hepatocyte-alone Models

Read More
Featured image for “Integration of Transcriptomic Point of Departure Metrics Into the MoAviz Visualization Framework”
March 19, 2020

Integration of Transcriptomic Point of Departure Metrics Into the MoAviz Visualization Framework

Read More
Featured image for “Clarenburg Lecture to feature renowned toxicologist at College of Veterinary Medicine”
October 15, 2019

Clarenburg Lecture to feature renowned toxicologist at College of Veterinary Medicine

Read More
Featured image for “Shiloh J. Barfield appointed as Vice President of Global Business Development”
September 24, 2019

Shiloh J. Barfield appointed as Vice President of Global Business Development

Read More
Featured image for “ScitoVation launches a new partnering program”
August 22, 2019

ScitoVation launches a new partnering program

Read More
Prev 1 2 … 4 5 6 7 8 9 Next
Contact Us

6 Davis Drive, Suite 146,
Durham, NC 27709

© 2025 ScitoVation. Privacy Policy
  • Services
    • Common Problems We Solve
      • Predicting Equivalent Dose in Humans
      • Understanding the Mode of Action of a Compound
      • Screening and Assessing Lead Compounds
    • Technologies
      • In vitro to in vivo extrapolation (IVIVE)
      • PBPK Modeling
      • Toxicogenomic or Pharmacogenomic Studies
    • Organ Specific
      • Liver toxicity
      • Respiratory Toxicity
      • Thyroid toxicity
    • Industries
      • Chemical Manufacturers and Consumer Products
      • Industry Associations
      • Pharma
  • Publications
  • Tools
    • MoAVIZ
    • PLETHEM
    • TTC Data Mart
  • Resources
    • Blog
    • Webinar
    • Case Studies
  • About us
    • Our Story
    • Team
    • Mission, Vision, Values
    • Careers
    • Scitovation, LLC. PHS-Financial Conflict Of Interest (FCOI) Policy
    • News
  • Request For Quote